YOU SEARCHED BY...
SEARCH BY...
Country
- Canada(7)
- Finland(1)
- France(2)
- Germany(5)
- India(1)
- Italia (1)
- Spain(1)
- Sweden(1)
- The Netherlands(1)
- United Kingdom(2)
- United States(50)
Contract Service Directory
IDT Biologika
Company Headquarters
Am Pharmapark
Kreisfreie Stadt Dessau-Roßlau
Dessau-Rosslau, 06861
Germany
Other Locations
1405 Research Boulevard,
Rockville, MD 20850
United States
Contract Service Directory
- Analytical Methods Development
- Aseptic Processing
- Biologics Manufacturing
- Biosimilars
- Clinical Trials, Phase I
- Clinical Trials, Phase II
- Clinical Trials, Phase III
- Clinical Trials, Phase IV
- Cold Chain Management
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Contract Packaging
- Custom Manufacturing
- Dosage Form Development
- Drug Development Services
- Filling, Syringe
- Filling, Vial
- Formulation Development
- Gene Therapy & Testing Protocols
- Lyophilization
- Manufacturing, API
- Manufacturing, Aseptic Fill/Finish
- Manufacturing, Biologics
- Manufacturing, Clinical Trials Supply
- Manufacturing, Custom
- Manufacturing, Dose Form, Sterile
- Manufacturing, Injectables
- Manufacturing, Lyophilized Products
- Manufacturing, Oral Drug Delivery
- Manufacturing, Parenterals, Large Volume
- Manufacturing, Parenterals, Small Volume
- Manufacturing, Proteins
- Manufacturing, Syringes, Pre-filled
- Manufacturing, Vaccines
- Methods Validation
- Packaging, Clinical Trial Materials
- Packaging, Clinical Trials
- Packaging, Glass Vials
- Packaging, Liquids
- Packaging, Parenterals
- Packaging, Unit Dosage
- Parenterals, Syringe Filling
- Parenterals, Vial Filling
- Process Characterization
- Process Development/Scale-Up Services
- Serialization
- Syringe Filling
Content From IDT Biologika
-
IDT Biologika is increasing its production capacity of vaccines
Saxony-Anhalt's Prime Minister Reiner Haseloff visited the new facilitiesNews Releases Released on 01.21.2022
-
IDT Biologika Fact Sheet
Advancing Biologics. Protecting Life.Literature / Brochures Released on 01.07.2022
-
IDT Biologika Brochure
Contract Development and Manufacturing of Live Viral Vaccines, Viral Vectors for Gene and Immune Therapeutics, and Fill/Finish of BiologicsLiterature / Brochures Released on 01.07.2022
-
IDT Biologika Paper on Expanding Viral Vectors
Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead TechnologyWhite Papers / Tech Papers Released on 01.07.2022
-
IDT Biologika Paper on Viral Vectors and Vaccines
Viral Vectors, Vaccines - A New Era of Collaborative DesignWhite Papers / Tech Papers Released on 01.07.2022
-
IDT Biologika Paper on Developing Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and ManufacturingWhite Papers / Tech Papers Released on 01.07.2022
-
IDT Biologika on the Production of Inactivated COVID-19 Vaccine
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001News Releases Released on 01.07.2022
-
IDT Biologika Corporate Video
Single Source CDMO Partner for Clinical Test Material and Commercial ProductsVideos Released on 01.07.2022
-
VideoBites: IDT Biologika
IDT Biologika specializes in the production of innovative live viral vaccines, viral vectors for gene and immune therapeutics, oncolytic viruses and more.Videos Released on 08.12.2021
Related Content
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
Novel AAV capsid Anc80 enables efficient gene transfer.02.01.23
-
Breaking News | Facilities | Industry News
Lonza Breaks Ground on Commercial Drug Product Facility in Stein
Milestone for the development of Lonza’s first large-scale drug product manufacturing facility based in Stein.02.01.23
-
Breaking News | Promotions & Moves
Exothera Names Darren Leva as Chief Business Officer
Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.02.01.23
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
New CDMO Vector BioMed Launches Operations
The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.02.01.23
-
Breaking News | Financial Reports
Pfizer Revenues Soar to Record-Breaking $100B in 2022
Comirnaty and Paxlovid rake in $56.7 billion in 2022 while sales of these COVID products are expected to decline as much as 60% in 2023.01.31.23
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 03.15.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Facilities | Industry News
CoreRx, Aimmune Unveil Joint Expansion
Together will advance treatment of peanut and other food allergies06.13.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
Lonza Acquires PharmaCell
Offers core expertise in autologous cell and gene therapy manufacturing06.05.17
-
Breaking News | Promotions & Moves
-
Breaking News | Facilities | Industry News | Inspections
-
Fast Investigation Response Solving Team (F.I.R.S.T.): Narrowing Timeframes To Resolve Quality Issue
Pharma Tech Industries recently launched F.I.R.S.T.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Industry News
Kemwell Provides Services for U.S. Trial
Supplies biologics drug substance for phase 1 clinical trials for U.S. IND filing05.18.17
-
Saneca Pharma Expands Services in Russia
Receives confirmation of multi-dosage cGMP approval for Russia05.16.17
-
New Molding Capability Enhances Product Quality And Shortens Supply Chain
How Pharma Tech Industries Proactively Turned A Challenge Into An Opportunity To Better Serve Customers.
-
Aseptic Processing | Fill/Finish | Injectables | Vials
Newsmakers: Peter Soelkner
A conversation with Peter Soelkner, managing director, Vetter Pharma International GmbHTim Wright, Contract Pharma 04.03.17
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Fujifilm Launches Bio CDMO Division
Aiming to achieve 100 billion yen in revenue by FY2024/March03.02.17
-
Bioanalytical Services | Industry News | Inspections
WuXi AppTec Bioanalytical Service Unit Passes FDA Inspection
Shanghai facility successfully completes audit and bioequivalence inspection03.01.17
-
QA/QC | Regulatory Affairs
FDA’s Quality Agreements Guidance
Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for IndustryPaul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17
-
Biologics, Proteins, Vaccines | Drug Discovery | Industry News
Eurofins Genomics Expands Express Oligo Service
Express Oligo service aims to allow more customers to receive primers in a shorter turnaround time01.17.17
-
Breaking News | Industry News
IDT Biologika Establishes Animal Health Biz in U.S.
Veteran biopharma industry business officer José Ochoa will lead the new organization01.12.17
-
cGMP Manufacture | Clinical Trials | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Fill/Finish | Process Development | Supply Chain
CMC Biologics, IDT Biologika Partner on ADCs Services
Aims to provide more complete and efficient services for the manufacture of ADCs02.17.16
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development | Serialization | Vials
IDT Biologika, Oncotec Invest in Expansion Projects
To expand vaccine and oncology capacity at IDT’s BioPharmaPark10.21.13
